Recent Advances in Premature Ejaculation: The Evidence

Premature ejaculation is the most common male sexual complaint, yet it is also among the most quietly endured. Many men never raise it, and those who do are often offered a single technique or a single tablet without a proper assessment of which type of PE they have.

This guide, the second volume in the Lumora Wellness Patient Education Series, sets out what has genuinely advanced in PE care. As in Volume One, every approach is placed in an honest evidence tier — established, emerging, or experimental — so that the newest option is not mistaken for the best one.

Understanding Premature Ejaculation

Premature ejaculation is ejaculation that occurs sooner than desired, with minimal stimulation, causing distress. The distress element matters: brief latency without personal or relationship impact is not, in itself, a disorder.

PE is classified into two forms, and the distinction shapes treatment:

• Lifelong PE — present since first sexual experiences. It is thought to have a strong neurobiological component, including heightened penile glans sensitivity and altered serotonin (5-HT) receptor signalling
• Acquired PE — developing later, often with an identifiable trigger. It is more often linked to erectile dysfunction, prostatitis, thyroid dysfunction, or psychological factors

How Premature Ejaculation Is Diagnosed

Assessment is largely clinical, and more informative than many men expect:

• Detailed history, including intravaginal ejaculatory latency time (IELT) — either patient-estimated or partner-timed
• Validated tools — the Premature Ejaculation Diagnostic Tool (PEDT) and Premature Ejaculation Profile (PEP)
• Screening for coexisting erectile dysfunction, which changes the treatment sequence
• Examination and, where indicated, hormonal and prostate assessment

That third point deserves emphasis. ED and PE frequently occur together, and when both are present the ED is generally addressed first — because anxiety about losing an erection can itself drive rapid ejaculation. If you suspect both, our guidance on erectile dysfunction assessment and care covers that side of the picture.

Standard Treatments

Established Care

These options have the strongest evidence base and remain the foundation of care:

• Behavioural therapy — stop-start and squeeze techniques, sex therapy, pelvic floor training
• Topical anaesthetics — lidocaine-prilocaine cream or spray applied before intercourse
• On-demand or daily SSRIs (off-label) — paroxetine, sertraline, fluoxetine
• Dapoxetine — a short-acting SSRI specifically developed and, in many countries including the UAE, approved for on-demand use in PE

Combination approaches — topical plus oral plus behavioural — tend to outperform any single modality. This is one of the more consistent findings in the field, and it is often the simplest gain available to a man who has only ever tried one thing.

Oral Medication: Where Things Stand

Established Care

Dapoxetine remains the benchmark on-demand oral option because of its rapid onset and short half-life, which avoids the build-up seen with daily SSRIs. Taken only when needed, it sidesteps much of the burden of continuous medication.

Newer interest has focused on two areas:

• Combination PDE5-inhibitor and SSRI regimens for men with mixed PE and ED — treating both mechanisms rather than one
• Tramadol as an off-label alternative in selected cases, used cautiously given its dependency potential

Recent Advances: Local and Injectable Therapies

Hyaluronic Acid Glans Augmentation

Emerging Research

Injecting hyaluronic acid gel into the glans penis is thought to dampen tactile hypersensitivity — one of the proposed drivers of lifelong PE. Rather than altering serotonin signalling systemically, it targets the sensory input directly.

• A 2025 randomised comparative study of 60 men found HA glans injection significantly increased intravaginal ejaculatory latency time, with a larger effect than botulinum toxin in the same trial
• A dedicated randomised trial comparing HA using the Fanning technique directly against botulinum toxin A is now underway, enrolling 80 men, to confirm and extend these findings
• Effects are temporary. HA is gradually resorbed, so repeat treatment is typically required

This is currently the most encouraging signal among the newer injectable options — but the evidence base is a small number of trials, not decades of data, and the temporary nature of the effect should be clear before anyone proceeds.

Botulinum Toxin

Emerging Research

Botulinum toxin A injected into the bulbospongiosus muscle is designed to reduce the intensity of the ejaculatory reflex contraction — a different mechanism from HA, targeting the muscular response rather than sensory input.

• Randomised trials show a measurable increase in IELT compared with placebo, though the effect appears smaller and less consistent than HA glans augmentation in head-to-head data
• One placebo-controlled trial found botulinum toxin safe but did not demonstrate clear superiority over placebo for lifelong PE — underlining that results vary across studies and injection techniques

Platelet-Rich Plasma for PE

Early / Experimental

• Interest is extrapolated from PRP's use in erectile dysfunction and Peyronie's disease. Direct trial evidence specifically for PE is still very limited
• The proposed mechanism — a neuromodulatory and regenerative effect on penile sensory nerve endings — remains theoretical for this indication

Emerging Regenerative and Device-Based Approaches

The approaches below appear in advertising more often than the evidence justifies. They are included so that patients can recognise where they actually sit.

Exosomes and Secretome

Early / Experimental

• These have not yet been studied in dedicated PE trials. Interest is extrapolated from regenerative work in ED and nerve injury
• Any use for premature ejaculation at this time should be considered strictly exploratory

Neuromodulation, Cryotherapy and Radiofrequency

Early / Experimental

• Selective dorsal penile neurectomy, a surgical option, has randomised evidence in carefully selected lifelong PE — but it is invasive and reserved for refractory cases
• Radiofrequency and cryotherapy approaches to reduce glans sensitivity are described in small case series; robust comparative trials are lacking
• These remain minority, evidence-light approaches and are not standard care

How the Evidence Compares

Therapy	Evidence Base	Typical Effect on IELT
Dapoxetine (on-demand SSRI)	Multiple large RCTs	2–3× baseline; well established
Topical anaesthetic	Multiple RCTs	Consistent, moderate increase
Hyaluronic acid (glans)	RCTs including 2025 comparative trial	Meaningful increase; temporary
Botulinum toxin A	RCTs, mixed results	Modest; less consistent than HA
PRP / exosomes	Extrapolated; minimal direct data	Not yet established for PE

Benefits and Limitations

Approach	Benefit	Limitation
Behavioural + topical	No systemic side effects, low cost	Requires consistency; modest ceiling effect
Dapoxetine	Rapid onset, on-demand, well studied	Nausea and dizziness in a minority
HA glans augmentation	Good early efficacy signal; single visit	Temporary; injection discomfort; limited long-term data
Botulinum toxin	Single procedure; established safety profile in other indications	Inconsistent efficacy for PE specifically

Safety Considerations

• SSRIs and dapoxetine — monitor for nausea, dizziness and rare mood effects; avoid combining with other serotonergic drugs
• Topical anaesthetics — partner sensitivity reactions are possible; condom use reduces transfer
• HA and botulinum toxin injections — bruising, transient swelling and injection discomfort are the main procedural risks. Both should be performed by an experienced injector

How We Approach This at Lumora Wellness

Lumora Wellness is a Dubai-based centre for evidence-informed men's health, regenerative medicine and longevity care, operating under DHA-compliant clinical governance. The practice is led by Dr. S. S. Vasan, a UroAndrologist and Surgical Andrologist with 37 years of clinical experience, DHA Specialist Licence holder, founder of SASSM, and author of four Springer textbooks in Andrology.

Our sequence follows the evidence rather than the novelty. We establish whether PE is lifelong or acquired, screen for coexisting erectile dysfunction and treatable triggers, and optimise established therapy — usually in combination — before newer injectables enter the conversation. Where HA or botulinum toxin is appropriate, its temporary nature and current guideline status are stated plainly.

Lumora Wellness works alongside URO Diagnostic Clinic in Dubai Healthcare City and an international clinical and research network spanning andrology, reproductive medicine and regenerative therapeutics.

Explore our premature ejaculation treatment in Dubai

Frequently Asked Questions

Is PE a psychological problem or a physical one?

Often both. Lifelong PE has a strong biological basis in nerve sensitivity and serotonin signalling, while acquired PE more often has situational or physical triggers. Treatment usually addresses both dimensions.

How long does a hyaluronic acid glans injection last?

Effects are typically measured in months rather than being permanent, since the gel is gradually resorbed. Repeat treatment is often needed, and this should be factored into any decision.

Can I combine dapoxetine with a topical anaesthetic?

Combination approaches are commonly used in clinical practice and often outperform either alone, but they should be tailored individually rather than self-assembled.

What if I have both PE and erectile dysfunction?

This is common, and the sequence matters. Coexisting ED is generally addressed first, since anxiety about maintaining an erection can itself accelerate ejaculation. A proper assessment screens for both rather than treating the more obvious complaint alone.

Is surgery ever appropriate for premature ejaculation?

Rarely. Selective dorsal penile neurectomy has randomised evidence in carefully selected men with lifelong PE, but it is invasive and reserved for refractory cases after other options have been exhausted.

Why is dapoxetine preferred over ordinary SSRIs?

Its rapid onset and short half-life allow on-demand use, avoiding the accumulation and continuous side-effect burden associated with taking a daily SSRI for this purpose.

Take the Next Step

Premature ejaculation is common, treatable, and nothing to be embarrassed about. What has genuinely improved in recent years is the range of options for men who have not responded to first-line therapy — alongside a clearer understanding of which newer treatments hold up under scrutiny and which do not.

If you would like to discuss your own situation, including which newer therapies may suit your history and overall health, a consultation allows your history, goals and current evidence-based options to be reviewed together.

Book Your Private Consultation

Also experiencing erectile dysfunction?

PE and ED frequently coexist, and when both are present the treatment sequence changes. Our companion guide reviews what has genuinely advanced in ED care, tier by tier.

Read: Recent Advances in Erectile Dysfunction

Concerned about your overall health?

Male sexual function is closely tied to vascular, metabolic and hormonal health. A comprehensive Health Longevity Check can assess your overall status and identify risk factors before they become serious.

Learn more about our Health Longevity Check in Dubai

References

1. Hyaluronic Acid vs Botulinum Toxin Injection in Treatment of Lifelong Drug-Resistant Premature Ejaculation: Randomized Study. ClinicalTrials.gov NCT07236632, 2025.
2. Hyaluronic acid versus botulinum-A toxin injection in the treatment of premature ejaculation: a comparative study. Scientific Reports. 2025.
3. Effect of bulbospongiosus muscle injection with botulinum-A toxin for treatment of lifelong premature ejaculation: a randomized controlled trial. International Journal of Impotence Research. 2024.
4. Henriques et al. A systematic review on administration of botulinum toxin in the management of male sexual dysfunctions. Andrology. 2025.
5. Abdallah H, Abdelnasser T, Hosny H, et al. Treatment of premature ejaculation by glans penis augmentation using hyaluronic acid gel: a pilot study. Andrologia. 2012;44:650–653.